Skip to content

Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels

Multicenter, Retrospective, Observational Clinical Study to Evaluate Clinical Outcome Measures and Safety Profiles for Patients With SDDD Treated With STALIF® C, or M, Ti or FLX Implants for 1 and 2 Levels.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05610397
Acronym
Stalif
Enrollment
200
Registered
2022-11-09
Start date
2023-04-24
Completion date
2024-09-30
Last updated
2023-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease, Grade 1 Spondylolisthesis, Retrolisthesis, Symptomatic Cervical Disc Disease

Keywords

Retrolisthesis, Grade 1 Spondyloisthesis, Degenerative Disc Disease, Symptomatic Cervical Disc Disease

Brief summary

This is a Retrospective, Observational Multi-Center study, utilizing patients diagnosed with up to a Grade1 spondylolisthesis or retrolisthesis or symptomatic degenerative disc disease and treated with STALIF® C, or M, Ti and/or FLX implants at one or two levels.

Detailed description

The study is intended to codify the performance of the STALIF family of products. Its design is to provide retrospective data derived from the patient's medical and surgical chart and prospectively assess the treating surgeon and patient on their level of satisfaction post-operative up to present. All subjects who sign an informed consent will be included in the prospective data collection via chart review at the individual investigational sites. The prospective data will come from subjects who complete the designated patient assessments as well as the treating surgeon. The data collection period will include surgeries performed between 2014 to present. The analysis will support the safety profile of the product family and allow for comparison to the available literature as well as between device types (Ti versus FLX). Furthermore, data from this study will support post-market surveillance requirements for the STALIF family of products.

Interventions

DEVICESTALIF®

STALIF® C, or M, Ti or FLX

Sponsors

Centinel Spine
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with up to a Grade1 spondylolisthesis or retrolisthesis or degenerative disc disease of the cervical or lumbar spine at time of surgery. * 2 levels, between: * C: C2-T1 (neck) * M: L2-S1 (low back) * Skeletally mature at the time of surgery with clinical and radiological evidence of degenerative disc disease of the cervical or lumbar spine.

Exclusion criteria

* Subject who had surgery with the STALIF devices at more than 2-levels. * In the Investigator's opinion, the subject diagnosed with a disease or condition, which precludes the possibility of healing at the time of surgery

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI) QuestionnaireChange from baseline at 24 monthsAssessing low back disability. Questionnaire consists of 10 sections with 6 possible choices in each section. Patient to choose 1 answer that best describes his/her ability to manage everyday activities. The questions weighted and summarized providing physical and mental health scores (PCS and MCS) ranging from 0 to 100. High scores indicating worse outcome and lower scores indicating better outcomes.
Neck Disability Index (NDI)Change from baseline at 24 monthsAssessing cervical neck disability questionnaire. Questionnaire consists of 10 sections with 6 possible choices in each section. Patient to choose 1 answer that best describes his/her ability to manage everyday life activities. The questions weighted and summarized providing physical and mental health scores (PCS and MCS) and range from 0 to 100. High scores indicating worse outcome and lower scores indicating better outcomes.

Secondary

MeasureTime frameDescription
Adverse EventsDay of surgery to 12 monthsAdverse events
Patient Self Satisfaction SurveyPost-op at 24 monthsSelf reported patient satisfaction survey consisting of 4 questions with 5 possible choices in each section. Patient to select one answer in each section. Scoring range from 0 to 100. Higher score extremely satisfied and lower score equals extremely dissatisfied.
Quality of Lift Questionnaire (SF-12) Prospective Arm of StudyPost-op at 24 months.SF-12 consists of 12 questions. Responses scored and summarized into physical and mental health composite scores (PCS and MCS) and range from 0 to 100. Higher score indicating better health. Score of 0 is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Surgeon Self Satisfaction SurveyPost-op at 24 monthsSurgeon Self Satisfaction Survey consists of 5 questions with 5 possible choices in each section. Surgeon to select one answer in each section. Scoring range from 0 to 100. Higher score extremely satisfied and lower score equals extremely dissatisfied.
Surgical InterventionsPost-op Day 1 of surgery to 6 monthsNo secondary surgical interventions.

Contacts

Primary ContactJames Kuras
j.kuras@centinelspine.com(484) 887-8829
Backup ContactKathleen Cascino, RN, BSHS
k.cascino@centinelspine.com(908) 967-7299

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026